Leukemia inhibitory factor is dysregulated in ankylosing spondylitis and contributes to bone formation

Aim Ankylosing spondylitis (AS) is a chronic inflammatory disease. However, the key inflammatory cytokines disrupted in this disease are not well defined. In this study, we performed protein array and multiple protein quantification to investigate the differentially expressed cytokines in plasma bet...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of rheumatic diseases 2022-05, Vol.25 (5), p.592-600
Hauptverfasser:	Kong, Weiping, Tang, Yulong, Tang, Kunhai, Yan, Zeran, Liu, Ting, Tao, Qingwen, Wang, Jiucun, Liu, Jing, Yan, Xiaoping
Format:	Artikel
Sprache:	eng
Schlagworte:	Alkaline phosphatase Ankylosing spondylitis Arthritis Bone growth Cbfa-1 protein cytokine Cytokines Humans inflammation Inflammation - metabolism Inflammatory diseases Interleukin-6 - metabolism Interleukins Kinases Leukemia Leukemia inhibitory factor Leukemia Inhibitory Factor - genetics Leukemia Inhibitory Factor - metabolism Leukemia Inhibitory Factor - pharmacology Magnetic resonance imaging mRNA Osteoblasts - pathology Osteogenesis Protein arrays Proteins Signal transduction Spondylitis, Ankylosing - diagnosis Spondylitis, Ankylosing - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!